MN-SBIR companies selected for Regenerative Medicine Grants

May 10, 2017

MHTA — Three Minnesota companies working with MN-SBIR were selected as recipients of grant funding from Regenerative Medicine Minnesota (RMM). Peyant Solutions, B-MoGen Biotechnologies, and MNPHARM were all selected among the group’s 2017 Biobusiness award winners.

MN-SBIR helps companies access non-dilutive federal research and development funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs as well as the RMM. MN-SBIR provides companies with education, training, resources, and consulting services to assist companies in applying for the federal funding.


Leah Hogdal, PhD, B-MoGen Biotechnologies: Mitochondrial Base Editing for Nerve Regeneration. B-MoGen Biotechnologies is the only company in the world to prove that they can edit the mitochondria genome in human cells.

John Schorgl, BA, Peytant Solutions, Inc.: AmnioStent™ ‐ Combining nitinol scaffold with amnion tissue to create a novel airway stent technology for tracheobronchial applications. Peytant Solutions, Inc. is a regenerative medical device company, incorporating human biomaterial with absorbable and alloy implant technologies. Their catheter delivered biologic implants offers regenerative solutions for patency, barriers and a rapid bio-integration in the treatment of all luminal diseases.

James R. Thompson, PhD, MNPHARM SBC: Molecular farming to reduce cost of recombinant proteins important to regenerative medicine. MNPHARM SBC is a manufacturer of recombinant proteins using a proprietary method called molecular farming. Their focused production is protein for nano-antibody and cancer therapeutics.

“Companies working with MN-SBIR are among some of the most cutting edge companies in the country and these grants from Regenerative Medicine Minnesota are evidence of that,” said Pat Dillon, MN-SBIR Director. “These companies are working on advancements that are well positioned to transform medicine and patient care.”

About the Minnesota High Tech Association (MHTA)

MHTA is an innovation and technology association united in fueling Minnesota’s prosperity and making Minnesota a top five technology state. We help bring together the people of Minnesota’s technology ecosystem and lead the charge in directing technology issues to Minnesota’s state capitol. MHTA is the only membership organization that represents Minnesota’s entire technology-based economy. MHTA members include organizations of every size − involved in virtually every aspect of technology creation, production, application and education in Minnesota. Find out more online at or follow MHTA on Twitter at


MN-SBIR is the State’s focal point to assist seed, early stage, emerging and existing firms (1-500 employees) to successfully access non-dilutive federal funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs. MN-SBIR is funded in part through a Cooperative Agreement with the U.S. Small Business Administration, the Department of Employment and Economic Development, the University of Minnesota – Office of Technology Commercialization, and MHTA. Learn more at


  • Join MHTA and our interim CEO, @LMSchlosser at our legislative reception on Tues, Jan. 22 at @Osborn370 to welcome…
  • Check out today's Life Sciences Workforce Wednesday report -- 500 current job openings. Interested in workforce iss…
  • Check out today's IT Workforce Wednesday report -- 500 current job openings in Life Sciences. Interested in workfor…
  • TECH Tuesday |   Spring Conference Call-for-Speakers -
  • Searching for more #WorkLifeBalance? Meet up with colleagues and friends at our next Women Leading in Technology (…
Follow Us ›